Zml Nasal Spray/Drop

This mechanism facilitates improved nasal airflow and eases breathing. Zml Nasal Spray/Drop is intended for short-term use, typically not exceeding 3 to 5 consecutive days, to prevent rebound congestion or rhinitis medicamentosa. It is administered intranasally, with dosage adjusted according to age and severity of symptoms. Caution is advised in patients with hypertension, cardiovascular disease, hyperthyroidism, diabetes, or prostatic hypertrophy, as systemic absorption may exacerbate these conditions.

Use during pregnancy and lactation should be under medical supervision. Common adverse effects include nasal irritation, dryness, and sneezing. Overuse may lead to nasal mucosal damage and dependency. Patients should avoid concurrent use with other sympathomimetic agents or monoamine oxidase inhibitors. Zml Nasal Spray/Drop provides rapid onset of action, typically within minutes, offering effective symptomatic relief of nasal congestion to enhance patient comfort and respiratory function.